Yongbo Shin
Yuseong, Republic of Korea
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Liver organoids for chemical risk assessment: biological fidelity, standardization, and context-of-use frameworks.
Journal: Archives of pharmacal research
Published: January 01, 2026
Efficient and reproducible generation of human induced pluripotent stem cell-derived expandable liver organoids for disease modeling.
Journal: Scientific reports
Published: September 20, 2023
A multicellular liver organoid model for investigating hepatitis C virus infection and nonalcoholic fatty liver disease progression.
Journal: Hepatology (Baltimore, Md.)
Published: May 24, 2023
Advances in liver organoids: model systems for liver disease.
Journal: Archives of pharmacal research
Published: February 23, 2022
Generation of human induced pluripotent stem cell line, KRIBBi003-A, from urinary cells of a patient with glycogen storage disease type IXa.
Journal: Stem cell research
Published: September 01, 2021
Generation of An Induced Pluripotent Stem Cell Line from Human Liver Fibroblasts from A Patient with Combined Hepatocellular-Cholangiocarcinoma.
Journal: Cell journal
Published: August 28, 2020
sEVs from tonsil-derived mesenchymal stromal cells alleviate activation of hepatic stellate cells and liver fibrosis through miR-486-5p.
Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: June 12, 2020
Blood-Stage Plasmodium Berghei ANKA Infection Promotes Hepatic Fibrosis by Enhancing Hedgehog Signaling in Mice.
Journal: Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology
Published: December 21, 2017
Showing 1-9 of 9
Last Updated: 09/26/2026